PHX — Pharmx Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- AU$74.81m
- AU$71.54m
- AU$7.32m
- 42
- 45
- 91
- 66
Annual cashflow statement for Pharmx Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.08 | 1.97 | 10.1 | 2.01 | -8.82 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.16 | 3.28 | 10.9 | 3.21 | -8.13 |
| Capital Expenditures | -4.09 | -3.98 | -3.36 | -1.58 | -1.75 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.1 | 0.336 | -0.213 | 3.33 | 1.06 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.19 | -3.64 | -3.57 | 1.75 | -0.695 |
| Financing Cash Flow Items | -0.427 | -0.043 | -0.012 | -0.016 | -0.015 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.18 | -0.361 | -0.325 | -4.62 | -0.136 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.16 | -0.719 | 7.05 | 0.33 | -8.96 |